New UKHSA and NHS England data reveal 18.6% of children have not received their pre-school booster vaccine, a vital vaccine for protecting against serious illnesses.
Long-term COVID-19 effects have been decreased from anywhere between 50 and 80% for those who have been vaccinated when compared to unvaccinated people.
Using almost $30 million in funding, an all-in-one vaccine is being developed to bring new protection against a range of new and existing coronavirus variants.
The most recent omicron subvariants have caused new infection spikes across the United States, as researchers find they are better at eluding vaccines.
A Phase 1 clinical trial of a universal flu vaccine has started inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Maryland.
